Business Context and Reporting Period
This Form 8-K is a current report filed by Predictive Oncology Inc. (not Axe Compute Inc.) on July 11, 2025, regarding an event that occurred on July 8, 2025. The company is incorporated in Delaware and its common stock (Ticker: POAI) trades on the NASDAQ Capital Market.
Key Financial Metrics
This filing does not contain financial statements, revenue, profit, cash flow, or debt metrics. The only financial data point disclosed is the stock price performance triggering the regulatory notice:
- Stock Price: Closed below $1.00 per share for 30 consecutive business days.
Material Changes
The material change reported is the receipt of a deficiency notice from the Nasdaq Listing Qualifications Department. The company is currently non-compliant with Nasdaq Marketplace Rule 5550(a)(2) (Minimum Bid Price Requirement). This notification has no immediate effect on the listing status of the common stock.
Outlook, Risks, and Management Commentary
Compliance Timeline: The company has 180 calendar days, until January 5, 2026, to regain compliance. Compliance is achieved if the bid price closes at or above $1.00 per share for 10 consecutive business days.
Contingencies and Risks:
- If compliance is not met by the deadline, the company may be eligible for a second compliance period if it meets other listing standards (e.g., market value of publicly held shares).
- Regaining compliance in the second period may require a reverse stock split.
- If the company fails to cure the deficiency or is deemed ineligible for additional time, Nasdaq may initiate delisting proceedings.
- The company may appeal a delisting determination, but there is no assurance of success.
Management Action: Management intends to actively monitor the bid price and consider available options to resolve the deficiency.
Investor Verification Checklist
- Verify the current trading price of POAI to assess proximity to the $1.00 threshold.
- Monitor future filings for announcements regarding a potential reverse stock split.
- Check the company's market capitalization and market value of publicly held shares to determine eligibility for a second compliance period if the initial deadline is missed.
- Review the company's cash position in upcoming 10-Q or 10-K filings, as this filing does not provide liquidity data.